Transcranial Magnetic Stimulation in Treatment of Attention Deficit/Hyperactivity Disorders
This study is not yet open for participant recruitment.
Verified June 2012 by Shalvata Mental Health Center
Sponsor:
Shalvata Mental Health Center
Information provided by (Responsible Party):
Shalvata Mental Health Center
ClinicalTrials.gov Identifier:
NCT01618110
First received: June 10, 2012
Last updated: June 18, 2012
Last verified: June 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
- ADHD is one of the most common psychiatric disorders.
- While most of the attention is directed towards youth, 60% continue to suffer symptoms into adult life.
- Current treatment is effective, but 30% suffer side effects that lowers QOL, and 20% are non-responders.
- Known mechanism of pathophysiology includes hypoactive dopaminergic system, especially at right PFC.
- It is this study hypothesis that by stimulating the right PFC by TMS, it will be possible to alleviate ADHD symptoms.
- A 10 sessions of treatment will by applied on a randomly allocated group of patients, diagnosed with ADHD, in a 2:1 ratio: The first group will receive an actual TMS treatment, and the second group will receive a sham treatment.
- Improvement of objective and subjective ADHD scale will be examined.
Condition | Intervention |
---|---|
Attention Deficit/Hyperactivity Disorder |
Device: Transcranial Magnetic Stimulation (Magstim, Rapid) Other: Placebo Treatment |
Study Type: | Interventional |
Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Outcomes Assessor) Primary Purpose: Treatment |
Official Title: | Transcranial Magnetic Stimulation of the Pre-Frontal Cortex in the Treatment of Attention Deficit/Hyperactivity Disorders: A Randomized, Controlled, Double Blind Study. |
Resource links provided by NLM:
Further study details as provided by Shalvata Mental Health Center:
Estimated Enrollment: | 30 |
Study Start Date: | July 2012 |
Estimated Study Completion Date: | July 2014 |
Estimated Primary Completion Date: | July 2014 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Active Comparator: Treatment Group |
Device: Transcranial Magnetic Stimulation (Magstim, Rapid)
Superficial rTMS, directed at right PFC, power of 100% of MT, 10Hz for 4 seconds, intervals of 30 seconds, 42 trains.
Other Names:
|
Sham Comparator: Sham group
Sham TMS coil (same noise, minimal magnetic field)
|
Other: Placebo Treatment
Sham coil (minimal magnetic field, same noise and feeling)
Other Names:
|
Eligibility
Ages Eligible for Study: | 21 Years to 50 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Age 18-50
- Established diagnosis of ADHD
- No C/I for TMS
- Has signed an informed consent form
Exclusion Criteria:
- Major Psychiatric disorders (Psychotic or Affective)
- Active use of drugs (4 weeks prior to participation)
- Neurologic disorder such as Epilepsy.
- No use of stimulants during the previous 7 days
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01618110
Contacts
Contact: Aviv Segev, MD | 972-9-7478-644 | aviv.segev@clalit.org.il |
Contact: Yuval Bloch, MD | 972-9-7478-510 | yuvalbl@clalit.org.il |
Locations
Israel | |
Shalvata MHC | Not yet recruiting |
Hod Hasharon, Israel | |
Contact: Aviv Segev, MD 972-9-7478-644 aviv.segev@clalit.org.il | |
Principal Investigator: Yuval Bloch, MD | |
Sub-Investigator: Aviv Segev, MD |
Sponsors and Collaborators
Shalvata Mental Health Center
Investigators
Principal Investigator: | Yuval Bloch, MD | Shalvata MHC |
More Information
No publications provided
Keywords provided by Shalvata Mental Health Center:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on October 17, 2012
No publications provided
Responsible Party: | Shalvata Mental Health Center |
ClinicalTrials.gov Identifier: | NCT01618110 History of Changes |
Other Study ID Numbers: | SH-12-0012 |
Study First Received: | June 10, 2012 |
Last Updated: | June 18, 2012 |
Health Authority: | Israel: Ministry of Health |
Keywords provided by Shalvata Mental Health Center:
ADHD Attention Deficit/Hyperactivity Disorder TMS Transcranial Magnetic Stimulation |
Additional relevant MeSH terms:
Attention Deficit Disorder with Hyperactivity Hyperkinesis Attention Deficit and Disruptive Behavior Disorders Mental Disorders Diagnosed in Childhood Mental Disorders |
Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms |
ClinicalTrials.gov processed this record on October 17, 2012